Wave Life Sciences saw the highest growth of 249% in patent filings in November and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 39% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Wave Life Sciences‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Wave Life Sciences has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with four publications in Q4 2023

The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings and grants with nearly 57% filings and 0% grants. The World Intellectual Property Organization(WIPO), United States(US), South Korea(KR), and European Patent Office(EPO) patent Office are among the top ten patent offices where Wave Life Sciences is filings its patents. Among the top granted patent authorities, Wave Life Sciences has 100% of its grants in China(CN)

Ionis Pharmaceuticals and Alnylam Pharmaceuticals could be the strongest competitors for Wave Life Sciences

In terms of grant share, Wave Life Sciences stands in fifth position among its competitors. Ionis Pharmaceuticals and Alnylam Pharmaceuticals secured the top positions according to recent patent publication data.

Patents related to rare diseases and cell & gene therapy lead Wave Life Sciences's portfolio

Wave Life Sciences has the highest number of patents in rare diseases followed by, cell & gene therapy and genomics. For rare diseases, nearly 50% of patents were filed and 100% of patents were granted in Q4 2023.

Cryopyrin-associated periodic syndromes related patents lead Wave Life Sciences portfolio followed by alpha-1 antitrypsin deficiency (a1ad)

Wave Life Sciences has highest number of patents in cryopyrin-associated periodic syndromes followed by alpha-1 antitrypsin deficiency (a1ad).

For comprehensive analysis of Wave Life Sciences's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.